CRISPONI, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 177.804
NA - Nord America 12.129
AS - Asia 3.828
SA - Sud America 596
AF - Africa 62
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 194.437
Nazione #
IT - Italia 173.564
US - Stati Uniti d'America 11.991
CN - Cina 1.743
SG - Singapore 1.464
UA - Ucraina 1.127
NL - Olanda 1.073
SE - Svezia 635
BR - Brasile 497
DE - Germania 483
GB - Regno Unito 315
FI - Finlandia 294
VN - Vietnam 160
KR - Corea 152
CA - Canada 102
FR - Francia 99
IN - India 79
RU - Federazione Russa 54
AR - Argentina 37
IR - Iran 33
ES - Italia 29
HK - Hong Kong 28
MX - Messico 26
TR - Turchia 26
BE - Belgio 25
JP - Giappone 25
IQ - Iraq 20
BD - Bangladesh 19
EC - Ecuador 18
PL - Polonia 18
AT - Austria 16
AU - Australia 15
ID - Indonesia 14
ZA - Sudafrica 13
CH - Svizzera 12
UY - Uruguay 11
EG - Egitto 9
IE - Irlanda 9
TN - Tunisia 9
PE - Perù 8
UZ - Uzbekistan 8
CL - Cile 7
CZ - Repubblica Ceca 7
MU - Mauritius 7
RO - Romania 7
NG - Nigeria 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
GR - Grecia 5
MA - Marocco 5
PT - Portogallo 5
PY - Paraguay 5
SK - Slovacchia (Repubblica Slovacca) 5
BG - Bulgaria 4
CO - Colombia 4
DZ - Algeria 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
LT - Lituania 3
PH - Filippine 3
PK - Pakistan 3
RS - Serbia 3
SY - Repubblica araba siriana 3
BH - Bahrain 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EE - Estonia 2
EU - Europa 2
HU - Ungheria 2
IL - Israele 2
IS - Islanda 2
MN - Mongolia 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AL - Albania 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 194.431
Città #
Cagliari 170.220
Uta 2.568
Fairfield 1.439
Woodbridge 1.072
Amsterdam 1.054
Ashburn 956
Houston 803
Chandler 767
Singapore 681
Dallas 618
Wilmington 609
Jacksonville 606
Ann Arbor 597
Boardman 579
Seattle 554
Cambridge 508
Nyköping 439
Dearborn 295
Beijing 248
Nanjing 194
Hefei 183
Los Angeles 174
Boston 160
Seoul 145
Helsinki 113
Santa Clara 112
Buffalo 93
New York 89
Shanghai 88
The Dalles 88
San Diego 70
Escalaplano 69
Nanchang 69
Milan 63
Guangzhou 60
Shenyang 56
Hebei 52
Redwood City 52
São Paulo 50
Ho Chi Minh City 49
Tianjin 47
Changsha 46
Toronto 45
Jiaxing 43
Redondo Beach 39
Verona 36
Mountain View 34
Norwalk 33
Atlanta 32
Dong Ket 30
Hanoi 30
London 30
Orange 29
Zhengzhou 29
Hong Kong 28
Sassari 28
Jinan 26
Brussels 25
Ottawa 25
Council Bluffs 23
Ningbo 22
Chicago 19
Tokyo 19
Pune 18
Auburn Hills 17
Brooklyn 16
Cedar Knolls 16
Hangzhou 16
Pars 16
Rio de Janeiro 14
Rome 14
Warsaw 14
Washington 13
Bari 12
Nuremberg 12
San Francisco 12
Turku 12
Columbus 11
Falls Church 11
Phoenix 11
Stockholm 11
Belo Horizonte 10
Curitiba 10
Fuzhou 10
Ankara 9
Charlotte 9
Jakarta 9
Padova 9
Wuhan 9
Dublin 8
Frankfurt am Main 8
Kunming 8
Redmond 8
Sinalunga 8
Spin 8
Taizhou 8
Bologna 7
Chennai 7
Johannesburg 7
Kilburn 7
Totale 187.765
Nome #
Iron Chelation for Iron Overload in Thalassemia 5.701
A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity 3.806
Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one 3.594
Complex formation equilibria of Cu2 + and Zn2 + with Irbesartan and Losartan 3.512
para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite 3.481
Multiple Sclerosis and environmental factors. 3.251
Metal coordination and tyrosinase inhibition studies with Kojic-βAla-Kojic 2.900
Searching for new aluminium chelating agents: a family of hydroxypyrone ligands 2.747
The essential metals for humans: a brief overview 2.656
Looking at new ligands for chelation therapy 2.509
A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies 2.396
A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays 2.371
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III) 2.262
Gold nanoparticles: A new golden Era in oncology? 2.222
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectives 2.194
A review on coordination properties of thiol-containing chelating agents towards mercury, cadmium, and lead 2.175
Do anti-diabetic drugs act as copper ligands? 2.159
Toxicity of nanoparticles: etiology and mechanisms 2.131
New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation 2.071
Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+ 2.031
Arsenic toxicity: Molecular targets and therapeutic agents 2.014
Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators 2.010
Complex formation equilibria of polyamine ligands with copper(II) and zinc(II) 1.962
Chelation therapy for metal intoxication. Comments from a thermodynamic view point 1.945
Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds 1.935
Editorial: Applications of Medicinal Bioinorganic Chemistry 1.914
Kill or cure: Misuse of chelation therapy for human diseases 1.897
The meaning of aluminium exposure on human health and aluminium-related diseases 1.885
Substituent effects on ionization constants as a predictive tool of coordinating ability 1.861
A new hydroxypyrone powerful chelator. From synthesis to AlIII, FeIII, CuII and ZnII complex formation equilibria, and structural characterization 1.855
Silver coordination compounds: A new horizon in medicine 1.832
Alarming use of chelation therapy 1.820
Chemical features of in use and in progress chelators for iron overload 1.805
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions 1.801
Iron III and aluminium III complexes with substituted salicyl-aldehydes and salicylic acids 1.789
State of art in chelating agents for the clinical treatment of metal poisoning 1.767
(5-Hydroxy-4-oxo-4H-pyran-2-yl)methyl3-({[(5-hydroxy-4-oxo-4H-pyran-2-yl)methoxy] carbonyl}amino) propanoate. Synthesis and its complex formation study 1.766
Comparison of selectivity of a family of chelating agents for trivalent (Al3+, Fe3+) and bivalent (Cu2+, Zn2+) metal ions 1.759
An NMR study on the 6,6'-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with Al(III) and Zn(II) ions 1.746
Hydroxypyrones, an intriguing family of chelating agents for Fe(III) and Al(III) 1.727
Noble metals in medicine: Latest advances 1.708
A speciation study on the perturbing effects of iron chelators on the homeostasis of essential metal ions 1.698
Chelating agents as therapeutic compounds - Basic principles 1.688
A family of hydroxypyrone ligands designed and synthesized for iron chelators 1.673
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.626
The Role of Magnesium in Pregnancy and in Fetal Programming of Adult Diseases 1.608
Uneven hepatic copper distribution in Wilson's disease 1.577
Chelating agents for human diseases related to aluminium overload 1.539
Uneven cardiac iron distribution in beta-thalassemia 1.490
Pyridoxamine driven selective turn-off detection of picric acid using glutathione stabilized fluorescent copper nanoclusters and its applications with chemically modified cellulose strips 1.407
Three-in-one type fluorescent sensor based on a pyrene pyridoxal cascade for the selective detection of Zn(ii), hydrogen phosphate and cysteine 1.327
Chelating agents for metal intoxication 1.276
The Potential Clinical Properties of Magnesium 1.251
Metal ion toxicity 1.215
Analytical determination of total acidity in some Sardinian wines: evaluation of the contribute of different acids 1.207
Iron chelating agents for iron overload diseases 1.206
null 1.188
Insights on alpha lipoic and dihydrolipoic acids as promising scavengers of oxidative stress and possible chelators in mercury toxicology 1.183
Warns against unapproved ‘chelation therapy’ 1.162
Substituent effects on ionisation and 13C NMR properties of some monosubstituted phenols. A potentiometric, spectrophotometric and 13C NMR study 1.128
Metal ions in the pathogenesis of Alzheimer’s disease: an open field 1.120
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 1.113
null 1.075
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson’s disease and beta-thalassemia 1.066
The aging kidney—as influenced by heavy metal exposure and selenium supplementation 1.061
Substituent effect on the stability of iron(III)-salicylate complexes. Structure of trans-[Fe(H5Nsal) 2(H2O)2]Cl·2H2O 1.043
A new hydroxypyrone chelating agent for FeIII and AlIII: a structural and equilibrium study 1.034
Potentiometric and spectrophotometric equilibrium study on Fe(III) and new catechol-bisphosphonate conjugates 1.031
Sampling variability in hepatic iron concentration in beta-thalassemia 991
Kojic derivatives: a promising class of iron(III) chelators 970
Enhancement of g-aminobutyric acid binding by Quazepam, a benzodiazepine derivative with preferential affinity for type I benzodiazepine receptors 943
A spectroscopic study on ionization of 2-, 3- and 4-aminopyridines 942
Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites 910
Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator 905
The outer/inner sphere dichotomy in the reaction of some adenine-like N-ligands with [Cu(H2EDTA)(H2O)] chelate 885
Different approaches to the study of chelating agents for iron and aluminium overload pathologies 884
Aluminium dependent human diseases, and chelating properties of aluminium chelators for bio-medical applications 870
Nickel binding sites in histone proteins: spectroscopic and structural characterization 858
null 845
A Chemometric analysis of metal ion content in Sardinian wines 825
Manganese and cobalt binding in a multi-histidinic fragment 809
Preface 804
Anomalies of the oral cavity in newborns 783
Complex formation equilibria of copper(II) with triethylentetramine and its human acetyl metabolites 755
Stress and ß-carbolines decrease the density of low affinity Gaba binding sites; an effect reversed by diazepam 754
Calculation of spectra parameters in several spectra by contemporary decomposition in the constituent Gaussian peaks 726
Divalent metal-acetate complexes in concentrated aqueous solutions. An X-ray diffraction and NMR spectroscopy study 723
Structural correlations in nickel(II)-thiodiacetato complexes: molecular and crystal structures and properties of [Ni(tda)(H2O)(3)] 701
Changes in the characteristics of low affinity of Gaba binding sites elicited by Ro15-1788 699
SUBSTITUENT EFFECTS OF NITRO GROUP ON THE COMPLEX FORMATION EQUILIBRIA OF SALICYLIC ACID AND CATECHOL WITH Fe(III) AND Al(III) IONS 685
null 678
Bisphosphonate chelating agents: complexation of Fe(III) and Al(III) by 1-phenyl-1-hydroxymethylene bisphosphonate and its analogues 668
null 666
Thiodiacetato-copper(II) chelates with or without N-heterocyclic donor ligands: molecular and/or crystal structures of [Cu(tda)](n), [Cu(tda)(Him)(2)(H2O)] and [Cu(tda)(5Mphen)] center dot 2H(2)O (Him = imidazole, 5Mphen=5-methyl-1,10-phenanthroline) 661
Chemometric methods applied to an ICP-AES study of chemical element distributions in autopsy livers from subjects affected by Wilson and beta-thalassemia 660
Brain copper, iron, magnesium, zinc, calcium, sulfur and phosphorus storage in Wilson's disease 659
Equilibrium constants of the Fe(III)dopamine system in aqueous solution 651
A windmill-shaped hexacopper(II) molecule built up by template core-controlled expansion of diaquatetrais(mu(2)-adeninato-N3,N9)dicopper(II) with aqua(oxydiacetato)copper(II) 649
Uneven element distribution in alcoholic liver disease. A case report 616
THIODIACETATE-COPPER(II) CHELATES WITH OR WITHOUT N-HETEROCYCLIC DONOR LIGANDS. CRYSTAL STRUCTURES OF [CU(TDA)]N, [CU(TDA)(HIM)2(H2O)] AND [CU(TDA)(5MPHEN)].2H2O 612
Totale 154.746
Categoria #
all - tutte 261.581
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 261.581


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122.414 0 0 0 0 0 6.362 4.999 3.278 1.210 2.699 2.162 1.704
2021/20228.541 1.083 959 497 772 751 678 521 326 596 687 881 790
2022/202311.356 922 1.154 1.175 826 942 1.268 548 1.937 802 571 719 492
2023/202412.856 746 532 575 997 1.394 2.210 1.777 829 517 1.068 1.120 1.091
2024/202528.715 7.253 7.466 3.352 2.552 1.431 1.515 2.380 203 420 1.370 319 454
2025/20263.531 563 379 1.242 736 530 81 0 0 0 0 0 0
Totale 194.854